Research and Markets: Pipeline and Commercial Insight: Migraine - Challenges Ahead for First-in-Class Developments | Business Wire

Links shared publicly online about this topic.

943
total visits

Research and Markets: Pipeline and Commercial Insight: Migraine - Challenges Ahead for First-in-Class Developments | Business Wire

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/40a4b4/pipeline_and_comme) has announced the addition of the "Pipeline and Commercial Insight: Migraine - Challenges Ahead for First-in-Class Developments" report to their offering. After 4 years of steady growth, the migraine market across the seven major regions was valued at $4.6 billion in 2008. However, following US patent expiries of both the acute migraine market leading brand, Imitrex (sum

View full resource at businesswire.com

Tags: Migraine, Migraine Medication, Triptans, Headache, Vascular Headache, Imitrex